Hot line:010-83057670
EN-
222026-06Another Breakthrough in Autoimmune Diseases! Leadingpharm Supports CD3×CD19 Bispecific Antibody Phase I Study Presented at EULAR 2026
-
182026-06International Authority Media Spotlight! Leadingpharm‑Enabled World’s First Non‑viral DMD Therapy Achieves Major Breakthrough
-
092026-06Breakthrough in Domestic Anti‑Influenza New Drug! Leadingpharm · Deep Blue Ocean Supports Approval of Jikeshu® Adolescent Indication
-
042026-06Good News | Kangleading Pharmaceutical Successfully Listed Among Hangzhou’s First Batch of “Good Seedling” Enterprises
-
162026-05Focusing on Clinical R&D Opportunities | Leadingpharm Shines at the 2026 DIA Drug Information Conference
010-83057670
Address：
Marketing Department：
Leadingpharm
Pharm News
010-61006450
